Supplier Type
- contract manufacturer
- Manufacturer
- Reagent
- custom synthesis
- Trader
Supplier Region
- Hyderabad(19)
- Ahmedabad(5)
- Maharashtra(123)
- Gujarat(99)
- Telangana(64)
- Karnataka(16)
- Tamil Nadu(8)
- Bangalore(4)
- AndhraPradesh(3)
- Punjab(5)
- Haryana(5)
- Mumbai(14)
- Uttar Pradesh(6)
- Rajasthan(4)
- Vadodara(2)
- New Delhi(17)
- West Bengal(6)
- Madhya Pradesh(8)
- GOA(1)
- Pune(1)
- Kolkata(1)
- Andhra Pradesh(2)
- Himachal Pradesh(1)
- NaviMumbai(1)
- Kerala(1)
Purity
- USP
- IP/BP/USP
- IP/BP/EP/USP
- IP / BP
- IH
- 99.55
- 99.50 %
- 99% Min
- 99%
- 98+
- 98%
- >98%
- 97%
- 96%
- 90 % Above
- 0.98
Package
- 100mg
- 102510 Kg / 25 Kg
- 0Metric Ton
- 0Std Packing
- 25mg
- 50mg
- 250mg
- 500mg
- 500g
- 5kg
- 25kg
- 2550025kg and 500 kg
- 10g
- 25g
- 50g
- 100g
- 1kg
- 10kg
- 20KG
- 50kg
- 500kg
- 1 kg
- 1grms kgs and MT
- 1grms to kgs
- 5 kg
- 10 kg
- 25kgs
- 50010500 mg and 1.0 gm
- 1grms kgs amd MT
- 100500100mg or 500 mg
- 100kg
- 1001100mg and 1 g
- 1MT
- 25125kg and 1 MT
- 50kgs
-
Atorvastatin lactone
125995-03-1
-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-
41411-66-9
-
CloMipraMine Related CoMpound C
-
2-Chloro-N-(2,6-dimethylphenyl)acetamide
1131-01-7
-
4-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfamide
16673-34-0
-
OLANZAPINE N-OXIDE
174794-02-6
-
GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE)
119018-30-3
-
Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
70844-48-3
-
3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2
-
Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
865792-18-3
Atorvastatin related compound H 125995-03-1
Doxycyline Related Compound-A 41411-66-9
100mg and 1 g 50mg 25mg
Glyburide Related Compound A 16673-34-0
1,2,3,4-Tetrahydrobenzo[H]Quinolin-3-ol 5423-67-6
